Trial intelligence / Profile preview

Custodiol-N vs Custodiol for heart transplantation organ perfusion

2012-001112-29Phase 3Completed

Sponsor
Franz Köhler Chemie
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of histidine-tryptophan-ketoglutarate solution (modified) in heart transplantation (2 arms), sponsored by Franz Köhler Chemie. Primary endpoint: CK-MB peak value. Started Jan 2015; status: completed.

02

Drugs

histidine-tryptophan-ketoglutarate solution (modified)
03

Conditions

heart transplantation

Beyond the preview

Go deeper on 2012-001112-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001112-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call